EAY191A3
OPEN TO ACCRUAL
A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancers
UW23105
OPEN TO ACCRUAL
Ph 1/2 Study of DCC-3116 w/ RAS/MAPK Pathway Inhibitors in Pts w/ Solid Tumors w/ RAS/MAPK Mutations
UW24010
OPEN TO ACCRUAL
Ph 1/2a Study of IMM-1-104, Oral MEK 1/2 Inhibitor in Pts w/ Previously Treated RAS Solid Tumors